For the Culture By The Culture
Gold Flora’s implosion wasn’t a one-off—it was a warning. From ballooned budgets to influencer-backed ego trips, Big Weed’s collapse in California shows what happens when hype and hubris replace substance and sustainability. We break it all down and expose how the industry got too loud, too fast, and now can’t afford the silence.
The DEA is delaying the rescheduling of marijuana from Schedule I, despite overwhelming scientific support and recommendations from health authorities. This stalling harms the cannabis industry, patients, and communities affected by marijuana criminalization. Political influences from big pharmaceutical companies contribute to this resistance, prolonging the adverse effects of current drug policies.
The $444 billion cannabis industry is coming—but not for you. While legacy growers and independent brands fight for survival, Big Tobacco, Big Pharma, and Wall Street are staking their claim. Who wins, who loses, and what the future of weed really looks like. Spoiler: It’s not as green as they promised.
Idaho’s House Bill 7 slaps a $300 fine on marijuana possession, but the real cost is much higher. From financial missteps to human suffering, we break it all down
California’s cannabis industry faces a credibility crisis as a pesticide scandal reveals flaws in testing protocols. Can new regulations restore trust?
Florida’s Amendment 3 tanked, sending shockwaves through the cannabis industry and tanking pot stocks. What does this failure mean for the future of legalization?
